Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 2Solid Tumors 1

Interventions

Pemetrexed 18Carboplatin 16Cisplatin 14Paclitaxel 9Gemcitabine 7pembrolizumab 6Crizotinib 5osimertinib 4amivantamab 4Nivolumab 4Docetaxel 4lazertinib 3Vinorelbine 3Ipilimumab 3Afatinib 3selpercatinib 2lorlatinib 2durvalumab 2cemiplimab 2atezolizumab 2alectinib 2Gefitinib 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2zenocutuzumab 1trastuzumab deruxtecan 1trametinib 1tepotinib 1telisotuzumab vedotin 1taletrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has announcements × Carcinoma, Non-Small-Cell Lung × alectinib × Clear all
NCT02075840 2026-05-29

ALEX

Hoffmann-La Roche

Phase 3 Completed
303 enrolled 32 charts 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03456076 2026-05-05

A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer

Hoffmann-La Roche

Phase 3 Active not recruiting
257 enrolled 14 charts 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡